A US Food and Drug Administration advisory committee is scheduled to meet in July 2026 to consider whether pharmacies should be permitted to compound and sell seven unapproved peptides, with BPC-157 among them
Its extended half-life profile makes it particularly valuable for studying sustained receptor engagement and downstream metabolic effects
Flip the vial upside down and pull out the required volume
doi: 10.3389/fphar.2021.632295 Received 07 December 2020 Accepted 13 April 2021 Published 10 June 2021 Volume 12 - 2021 Edited by Chiara Bianca Maria Platania, University of Catania, Italy Reviewed by Doreen Schmidl, Medical University of Vienna, Austria Francesca Lazzara, University of Catania, Italy Updates Copyright 2021 Zlatar, Kokot, Vuletic, Masnec, Kralj, Perisa, Barisic, Radic, Milanovic, Drmic, Seiwerth and Sikiric